These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 691199)

  • 1. Changes in theophylline clearance during acute illness.
    Vozeh S; Powell JR; Riegelman S; Costello JF; Sheiner LB; Hopewell PC
    JAMA; 1978 Oct; 240(17):1882-4. PubMed ID: 691199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
    Powell JR; Vozeh S; Hopewell P; Costello J; Sheiner LB; Riegelman S
    Am Rev Respir Dis; 1978 Aug; 118(2):229-38. PubMed ID: 697173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline clearance in obese patients in relation to smoking and congestive heart failure.
    Slaughter RL; Lanc RA
    Drug Intell Clin Pharm; 1983 Apr; 17(4):274-6. PubMed ID: 6839957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of disease states on theophylline elimination.
    Jenne JW
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):727-35. PubMed ID: 3534054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline disposition in Korean patients with congestive heart failure.
    Jeong CS; Hwang SC; Jones DW; Ryu HS; Sohn K; Sands CD
    Ann Pharmacother; 1994 Mar; 28(3):396-401. PubMed ID: 8193433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline clearance: effect of marked obesity.
    Blouin RA; Elgert JF; Bauer LA
    Clin Pharmacol Ther; 1980 Nov; 28(5):619-23. PubMed ID: 7438680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline toxicity--a consequence of congestive heart failure.
    LeGatt DF
    Drug Intell Clin Pharm; 1983 Jan; 17(1):59-60. PubMed ID: 6825561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in theophylline clearance after the administration of erythromycin to a patient with obstructive lung disease.
    Green JA; Clementi WA
    Drug Intell Clin Pharm; 1983 May; 17(5):370-2. PubMed ID: 6861626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline hemodialysis clearance.
    Blouin RA; Bauer LA; Bustrack JA; Record KE; Bivins BA
    Ther Drug Monit; 1980; 2(3):221-3. PubMed ID: 7222176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the "condition correction factor" method of estimating theophylline clearance.
    Gotz VP; Russell WL; Lopez LM
    Ther Drug Monit; 1983; 5(1):103-7. PubMed ID: 6845393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjustment of intravenous theophylline dosage according to serum concentration on admission and total body clearance.
    Laaban JP; Dupeyron JP; Guyon F; Lafay M; Drieu L; Rochemaure J; Fabiani P
    Eur J Respir Dis Suppl; 1986; 146():571-9. PubMed ID: 3465582
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of acute and chronic renal failure on theophylline clearance.
    Bauer LA; Bauer SP; Blouin RA
    J Clin Pharmacol; 1982 Jan; 22(1):65-8. PubMed ID: 7061728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ; Murphy JE
    Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum theophylline clearance with orally administered activated charcoal.
    Mahutte CK; True RJ; Michiels TM; Berman JM; Light RW
    Am Rev Respir Dis; 1983 Nov; 128(5):820-2. PubMed ID: 6638669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction.
    Yano I; Tanigawara Y; Yasuhara M; Okumura K; Kawakatsu K; Nishimura K; Hori R
    Biol Pharm Bull; 1993 May; 16(5):501-5. PubMed ID: 8364499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.